We summarize the week's scientific breakthroughs every Thursday.
The Trump administration has reportedly disrupted over 100 clinical trials. Science News spoke to researchers about the impacts on four of them.
Researchers are still divided about whether Spinosaurus was a swimmer or a wader. What’s clear is that confirming the first swimming dinosaur would be a game-changer.
People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.
An abundance of data show that SSRIs, a class of drugs commonly used as antidepressants, are effective, though, like any drug, they have risks.
As the Texas measles outbreak grows and HHS head RFK Jr. puts vaccines under new scrutiny, two experts answer questions about the public health tool.
Defining AI chatbot personality could be based on how a bot “feels” about itself or on how a person feels about the bot they’re interacting with.
Men have two birth control options: condoms and vasectomies. Why has it taken so long to develop more contraceptives?
A recent flurry of executive orders and surprise actions by the Trump administration have roiled WHO, the CDC and the international public health community.
As Trump takes office, issues of arms control, the U.S. arsenal and weapons testing will be on the radar for many nuclear weapons researchers.
